• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2020

View Archived Issues

AP-1 and antidepressant action

Read More

Candida auris: mostly, nothing wrong

Read More

BeiGene and Singlomics sign license agreement for SARS-CoV-2-neutralizing antibody drug candidates

Read More

Immutep and Monash University receive grant from ARC to extend their LAG-3 project

Read More

FDA accepts IND application for phase IIa study of SPR-720

Read More

Discovery of novel HIF-PHD2 inhibitors for the treatment of anemia

Read More

First preclinical data presented for ATI-2173, a novel compound for treating HBV

Read More

French investigators patent new acetylcholinesterase reactivators

Read More

Results from first clinical trial of KB-174 in patients with well-compensated cirrhosis

Read More

Merck KGaA synthesizes new KIT mutant inhibitors

Read More

Ardelyx divulges glycyrrhetinic derivatives for hyperkalemia

Read More

Maruho identifies new BRD4 inhibitors

Read More

New TYK2 ligands presented by Ventyx Biosciences

Read More

Regulatory loop modulates innate-adaptive immune crosstalk in fever

Read More

Anti-vimentin monoclonal antibody hzVSF-v13 safe in phase I trial

Read More

HH-2853 enters first-in-human study for NHL and advanced solid tumors

Read More

Oxurion begins phase II study of THR-149 for DME

Read More

Phase III study of Kevzara in severely or critically ill COVID-19 patients misses primary endpoint

Read More

FDA clears Sound Pharmaceuticals to begin phase II studies with ebselen in COVID-19

Read More

FDA approves Xaracoll for acute postsurgical pain relief following open inguinal hernia repair

Read More

GSK and Vir begin phase II/III study of anti-SARS-CoV-2 monoclonal antibody VIR-7831

Read More

Prevail opens phase I/II study of PR-006 in frontotemporal dementia with progranulin mutations

Read More

European approval for Imfinzi as first-line treatment of extensive-stage small cell lung cancer

Read More

Embera begins phase II study of EMB-001 for cocaine use disorder

Read More

FDA clears IND for clinical development of OMS-906 for PNH

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 2, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe